Ken Griffin Co Diagnostics, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.02 - $1.75 $2,754 - $4,725	2,700 Added 67.5%	6,700 $8,000
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.7 $808 - $1,360	800 Added 25.0%	4,000 $5,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.42 $12,296 - $16,472	-11,600 Reduced 78.38%	3,200 $3,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.5 $11,300 - $16,950	-11,300 Reduced 43.3%	14,800 $19,000
Q3 2023 Nov 14, 2023	BUY	$1.03 - $1.85 $1,339 - $2,405	1,300 Added 5.24%	26,100 $27,000
Q2 2023 Aug 14, 2023	BUY	$1.04 - $1.64 $1,144 - $1,804	1,100 Added 4.64%	24,800 $27,000
Q1 2023 May 15, 2023	BUY	$1.39 - $3.24 $15,706 - $36,612	11,300 Added 91.13%	23,700 $35,000
Q4 2022 Feb 14, 2023	SELL	$2.32 - $3.68 $5,568 - $8,832	-2,400 Reduced 16.22%	12,400 $31,000
Q3 2022 Nov 14, 2022	SELL	$2.87 - $7.01 $20,090 - $49,070	-7,000 Reduced 32.11%	14,800 $48,000

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.